» Articles » PMID: 38600347

Key Genes and Convergent Pathogenic Mechanisms in Parkinson Disease

Overview
Specialty Neurology
Date 2024 Apr 10
PMID 38600347
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson disease (PD) is a neurodegenerative disorder marked by the preferential dysfunction and death of dopaminergic neurons in the substantia nigra. The onset and progression of PD is influenced by a diversity of genetic variants, many of which lack functional characterization. To identify the most high-yield targets for therapeutic intervention, it is important to consider the core cellular compartments and functional pathways upon which the varied forms of pathogenic dysfunction may converge. Here, we review several key PD-linked proteins and pathways, focusing on the mechanisms of their potential convergence in disease pathogenesis. These dysfunctions primarily localize to a subset of subcellular compartments, including mitochondria, lysosomes and synapses. We discuss how these pathogenic mechanisms that originate in different cellular compartments may coordinately lead to cellular dysfunction and neurodegeneration in PD.

Citing Articles

Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions.

Liu W, Lu Y, Liu J, Yu Y, Yang H Acta Neuropathol Commun. 2025; 13(1):40.

PMID: 39994794 PMC: 11849190. DOI: 10.1186/s40478-025-01949-6.


Neuroprotective Effects of Myrtle Berry By-Product Extracts on 6-OHDA-Induced Cytotoxicity in PC12 Cells.

Dessi D, Fais G, Follesa P, Sarais G Antioxidants (Basel). 2025; 14(1).

PMID: 39857422 PMC: 11759165. DOI: 10.3390/antiox14010088.


Peripheral proteinopathy in neurodegenerative diseases.

Xu B, Lei X, Yang Y, Yu J, Chen J, Xu Z Transl Neurodegener. 2025; 14(1):2.

PMID: 39819742 PMC: 11737199. DOI: 10.1186/s40035-024-00461-6.


The Role and Mechanism of Metformin in the Treatment of Nervous System Diseases.

Li H, Liu R, Liu J, Qu Y Biomolecules. 2025; 14(12.

PMID: 39766286 PMC: 11673726. DOI: 10.3390/biom14121579.


Emerging and Promising Keywords in Biomolecules and Therapeutics for 21st Century Diseases.

Ko H, Lee C Biomol Ther (Seoul). 2024; 33(1):1-4.

PMID: 39725476 PMC: 11704395. DOI: 10.4062/biomolther.2024.007.


References
1.
Poewe W, Seppi K, Tanner C, Halliday G, Brundin P, Volkmann J . Parkinson disease. Nat Rev Dis Primers. 2017; 3:17013. DOI: 10.1038/nrdp.2017.13. View

2.
Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

3.
Jankovic J . Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008; 79(4):368-76. DOI: 10.1136/jnnp.2007.131045. View

4.
Blauwendraat C, Nalls M, Singleton A . The genetic architecture of Parkinson's disease. Lancet Neurol. 2019; 19(2):170-178. PMC: 8972299. DOI: 10.1016/S1474-4422(19)30287-X. View

5.
Jia F, Fellner A, Kumar K . Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing. Genes (Basel). 2022; 13(3). PMC: 8950888. DOI: 10.3390/genes13030471. View